Subretinal lipid exudation associated with untreated choroidal melanoma

Minija, C. K.; Shanmugam, Mahesh P.
May 2011
Indian Journal of Ophthalmology;May2011, Vol. 59 Issue 3, p233
Academic Journal
Subretinal lipid exudation in an untreated choroidal melanoma is very rare. It is seen following plaque radiotherapy in choroidal melanoma. There is only one case report of untreated choroidal melanoma with massive lipid exudation in a patient with metastatic hypernephroma. We report here a rare case of untreated choroidal melanoma with lipid exudation. Subretinal exudation that is rarely seen following plaque brachytherapy was noted at the borders of this untreated tumor. Lipid exudation partially resolved following brachytherapy.


Related Articles

  • Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report. Hiroshi Onishi; Tomonori Kawasaki; Hidenori Zakoji; Takashi Yoshida; Takafumi Komiyama; Kengo Kuriyama; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Licht Tominaga; Kan Marino; Iori Watanabe; Mitsuhiko Oguri; Tsutomu Araki; Nobuyuki Enomoto; Masayuki Takeda; Ryohei Katoh // BMC Research Notes;2014, Vol. 7 Issue 1, p3 

    Background Treatment of primary renal cell carcinoma using radiotherapy with curative intent is rare, because renal cell carcinoma is generally regarded as a radiation-resistant tumor. Recently, stereotactic body radiation therapy has been radically applied for cancers in various organs...

  • Clear Cell Sarcoma: An Institutional Review. Jacobs, Ira A.; Chang, C. K.; Guzman, Grace; Salti, George I. // American Surgeon;Apr2004, Vol. 70 Issue 4, p300 

    Clear cell sarcoma of the tendons and aponeuroses (CCSTA) is an aggressive, rare soft-tissue tumor representing approximately 1 per cent of all soft tissue sarcomas. Although it appears to be histogenetically related to melanoma, its clinical behavior resembles soft tissue sarcoma with a...

  • CirculatingType-1 anti-tumor CD4+ T cells are preferentially pro-apoptotic in cancer patients. Mandic, Maja; Taylor, Jennifer L.; Wesa, Amy K.; Storkus, Walter J.; Moschos, Stergios; Kirkwood, John M.; Kwok, William W.; Finke, James Harold // Frontiers in Oncology;Sep2014, Vol. 4, p1 

    Cancer patients frequently exhibit a deficiency in Type-1 (but not Type-2 or regulatory) CD4+ T cell responses against tumor-associated antigens (TAA), which may limit protection against disease progression or responsiveness to immunotherapy in these individuals. Since such deficiency was...

  • Clear cell sarcoma of soft tissue in right parapharyngeal region: report of a rare case. Chuifeng Fan; Juanhan Yu; Lianhe Yang; Xuyong Lin; Enhua Wang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p10935 

    Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is a rare malignant neoplasm typically involving deep soft tissue of the extremities, in close proximity to tendons and aponeuroses. Here we describe a case of clear cell sarcoma of the right parapharyngeal region in a...

  • Immunotherapy: Down the drain? Minton, Kirsty // Nature Reviews Cancer;Jul2003, Vol. 3 Issue 7, p472 

    Focuses on limitations of using interleukin-2 (IL-2) as a mode of treatment of malignant melanoma and renal-cell carcinoma. Revelation that high dose of IL-2 therapy developed capillary-leak syndrome in patients; Examination of the component of IL-2 which is responsible for unblocking plugholes...

  • Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Stinauer, Michelle A.; Kavanagh, Brian D.; Schefter, Tracey E.; Gonzalez, Rene; Flaig, Thomas; Lewis, Karl; Robinson, William; Chidel, Mark; Glode, Michael; Raben, David // Radiation Oncology;2011, Vol. 6 Issue 1, p34 

    Background: Melanoma and renal cell carcinoma (RCC) are traditionally considered less radioresponsive than other histologies. Whereas stereotactic body radiation therapy (SBRT) involves radiation dose intensification via escalation, we hypothesize SBRT might result in similar high local control...

  • CLEAR CELL SARCOMA: A CASE MIMICKING PRIMARY CUTANEOUS MALIGNANT MELANOMA. Rodríguez-Martín, M.; Sáez-Rodríguez, M.; Esquivel, B.; Sánchez González, R.; Cabrera, A. Noda; Herrera, A. Martín // Indian Journal of Dermatology;Apr-Jun2009, Vol. 54 Issue 2, p168 

    Clear cell sarcoma (CCS) is a recently described variant of sarcoma characterized by prominent clear cells showing features similar to clear cell melanoma. This neoplasm was first described by Dr. Franz M. Erzinger. Primary CCS usually arises in deeper soft tissues, in association with fascia,...

  • Nephrectomy results in longer survival than interferon alone in metastatic renal cell cancer patients. Flanigan, R. C.; Salmon, S. E.; Blumenstein, B. A. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p148 

    Deals with a study which aimed to determine whether nephrectomy affects survival in metastatic renal cell cancer patients. Methodology used in the study; Results and conclusion.

  • Renal cell carcinoma: incidental detection and pathological staging. Slow, W.Y.; Yip, S.K.H.; Ng, L.G.; Tan, P.H.; Cheng, W.S.; Foo, K.T. // Journal of the Royal College of Surgeons of Edinburgh;Oct2000, Vol. 45 Issue 5, p291 

    Studies the incidence of incidental renal carcinoma treated in Singapore General Hospital from 1990 to 1998. Pathological stage and survival of incidentally detected carcinoma; Survival between incidentally detected lesions and their symptomatic counterparts; Clinical presentation,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics